• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同时使用左炔诺孕酮宫内节育系统和依托孕烯皮下埋植剂治疗重度青春期子宫内膜异位症。

Simultaneous use of a levonorgestrel intrauterine system and an etonogestrel subdermal implant for debilitating adolescent endometriosis.

作者信息

Al-Jefout Moamar, Palmer John, Fraser Ian S

机构信息

Department of Obstetrics and Gynaecology, Queen Elizabeth II Research Institute for Mothers and Infants, University of Sydney, New South Wales, Australia.

出版信息

Aust N Z J Obstet Gynaecol. 2007 Jun;47(3):247-9. doi: 10.1111/j.1479-828X.2007.00727.x.

DOI:10.1111/j.1479-828X.2007.00727.x
PMID:17550495
Abstract

Adolescent familial endometriosis may cause severe and persistent symptoms that are disruptive to lifestyle. Treatment may be difficult in many cases. We describe the novel and successful first use of a simultaneous combination of a levonorgestrel intrauterine system and an etonogestrel subdermal implant in a teenager with severe pain symptoms as a result of laparoscopically confirmed endometriosis, which was refractory to other treatments.

摘要

青少年家族性子宫内膜异位症可能会导致严重且持续的症状,扰乱生活方式。在许多情况下,治疗可能会很困难。我们描述了首例成功地同时联合使用左炔诺孕酮宫内节育系统和依托孕烯皮下植入剂治疗一名青少年患者的案例,该患者因腹腔镜确诊的子宫内膜异位症而出现严重疼痛症状,且对其他治疗方法无效。

相似文献

1
Simultaneous use of a levonorgestrel intrauterine system and an etonogestrel subdermal implant for debilitating adolescent endometriosis.同时使用左炔诺孕酮宫内节育系统和依托孕烯皮下埋植剂治疗重度青春期子宫内膜异位症。
Aust N Z J Obstet Gynaecol. 2007 Jun;47(3):247-9. doi: 10.1111/j.1479-828X.2007.00727.x.
2
Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.依托孕诺酮释放型避孕埋植剂和 52 毫克左炔诺孕酮释放宫内节育系统控制子宫内膜异位症相关疼痛:随机临床试验。
Fertil Steril. 2018 Nov;110(6):1129-1136. doi: 10.1016/j.fertnstert.2018.07.003.
3
A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel-releasing intrauterine system.对使用左炔诺孕酮宫内节育系统的子宫内膜异位症和盆腔疼痛女性进行的3年随访。
Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):128-9. doi: 10.1016/j.ejogrb.2008.12.012. Epub 2009 Jan 31.
4
Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial.使用ENG避孕植入剂或52毫克左炔诺孕酮宫内节育系统评估子宫内膜异位症相关性疼痛女性的生物标志物:一项非劣效性随机临床试验。
Eur J Contracept Reprod Health Care. 2018 Oct;23(5):344-350. doi: 10.1080/13625187.2018.1531117. Epub 2018 Oct 29.
5
Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months.使用依托孕烯释放皮下植入剂或含52毫克左炔诺孕酮宫内节育系统长达24个月的子宫内膜异位症相关疼痛评分和生物标志物。
Eur J Contracept Reprod Health Care. 2020 Apr;25(2):133-140. doi: 10.1080/13625187.2020.1725461. Epub 2020 Feb 18.
6
Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study.左炔诺孕酮宫内节育系统和依托孕烯植入剂的可接受性:一项观察性研究的一年结果。
Eur J Contracept Reprod Health Care. 2012 Feb;17(1):79-88. doi: 10.3109/13625187.2011.636088. Epub 2011 Dec 27.
7
Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.依托孕烯植入剂和左炔诺孕酮宫内节育器的长期使用:超出美国食品药品监督管理局批准使用期限两年。
Am J Obstet Gynecol. 2017 Jun;216(6):586.e1-586.e6. doi: 10.1016/j.ajog.2017.01.036. Epub 2017 Jan 29.
8
Efficacy of the levonorgestrel-releasing intrauterine device in the treatment of recurrent pelvic pain in multitreated endometriosis.左炔诺孕酮宫内节育器治疗多次治疗的子宫内膜异位症复发性盆腔疼痛的疗效
J Reprod Med. 2011 Nov-Dec;56(11-12):497-503.
9
Medicated intrauterine systems for treatment of endometriosis-associated pain.用于治疗子宫内膜异位症相关性疼痛的含药宫内节育系统
J Minim Invasive Gynecol. 2006 Nov-Dec;13(6):535-8. doi: 10.1016/j.jmig.2006.06.010.
10
The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis.左炔诺孕酮宫内节育器可降低子宫内膜异位症患者的血清CA-125水平。
Fertil Steril. 2006 Sep;86(3):742-4. doi: 10.1016/j.fertnstert.2006.02.082. Epub 2006 Jun 19.

引用本文的文献

1
Contraception and endometriosis: challenges, efficacy, and therapeutic importance.避孕与子宫内膜异位症:挑战、疗效及治疗意义
Open Access J Contracept. 2015 Jul 27;6:105-115. doi: 10.2147/OAJC.S56400. eCollection 2015.
2
Recognising, understanding and managing endometriosis.认识、理解和管理子宫内膜异位症。
J Hum Reprod Sci. 2008 Jul;1(2):56-64. doi: 10.4103/0974-1208.44112.